Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Janney currently holds 5,000 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Janney has been a net seller of KRYS stock. They have purchased $29.7M and sold $63.7M worth of shares.
Daniel Janney's most recent insider trade was on Jun 30, 2024, when they sold 5,000 shares at $0.00 per share.
Daniel Janney serves as Executive at Krystal Biotech, Inc. (KRYS). They have executed 88 insider transactions totaling $93.3M over their tenure at the company.
Daniel Janney holds the position of Executive at Krystal Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Daniel Janney has shown a selling trading pattern, with $29.7M in total purchases and $63.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel Janney was on Dec 10, 2021, when they sold $7.0M worth of KRYS shares. This transaction involved 100,000 shares at $70.50 per share.
Daniel Janney currently owns 5,000 shares of Krystal Biotech, Inc. (KRYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Janney's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Janney has 88 Form 4 filings on record as an insider at Krystal Biotech, Inc..
Set alerts for Daniel Janney and 40,000+ other insiders.